113 related articles for article (PubMed ID: 3262528)
1. Long-term persistence of human anti-murine antibody responses following radioimmunodetection and radioimmunotherapy of cutaneous T-cell lymphoma patients using 131I-T101.
Goldman-Leikin RE; Kaplan EH; Zimmer AM; Kazikiewicz J; Manzel LJ; Rosen ST
Exp Hematol; 1988 Nov; 16(10):861-4. PubMed ID: 3262528
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunotherapy of patients with cutaneous T-cell lymphoma using an iodine-131-labeled monoclonal antibody: analysis of retreatment following plasmapheresis.
Zimmer AM; Rosen ST; Spies SM; Goldman-Leikin R; Kazikiewicz JM; Silverstein EA; Kaplan EH
J Nucl Med; 1988 Feb; 29(2):174-80. PubMed ID: 3258022
[TBL] [Abstract][Full Text] [Related]
3. Human immune response to multiple injections of murine monoclonal IgG.
Shawler DL; Bartholomew RM; Smith LM; Dillman RO
J Immunol; 1985 Aug; 135(2):1530-5. PubMed ID: 3874237
[TBL] [Abstract][Full Text] [Related]
4. Induction of in vitro and in vivo antigenic modulation by the anti-human T-cell monoclonal antibody T101.
Shawler DL; Miceli MC; Wormsley SB; Royston I; Dillman RO
Cancer Res; 1984 Dec; 44(12 Pt 1):5921-7. PubMed ID: 6333922
[TBL] [Abstract][Full Text] [Related]
5. Continuous infusion of T101 monoclonal antibody in chronic lymphocytic leukemia and cutaneous T-cell lymphoma.
Dillman RO; Beauregard J; Shawler DL; Halpern SE; Markman M; Ryan KP; Baird SM; Clutter M
J Biol Response Mod; 1986 Oct; 5(5):394-410. PubMed ID: 3490543
[TBL] [Abstract][Full Text] [Related]
6. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G
Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181
[TBL] [Abstract][Full Text] [Related]
7. Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.
Foon KA; Oseroff AR; Vaickus L; Greenberg SJ; Russell D; Bernstein Z; Pincus S; Köhler H; Seon BK; Tahaoglu E
Clin Cancer Res; 1995 Nov; 1(11):1285-94. PubMed ID: 9815923
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council Study.
Rosen ST; Zimmer AM; Goldman-Leikin R; Gordon LI; Kazikiewicz JM; Kaplan EH; Variakojis D; Marder RJ; Dykewicz MS; Piergies A
J Clin Oncol; 1987 Apr; 5(4):562-73. PubMed ID: 3549989
[TBL] [Abstract][Full Text] [Related]
9. Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy.
Schroff RW; Foon KA; Beatty SM; Oldham RK; Morgan AC
Cancer Res; 1985 Feb; 45(2):879-85. PubMed ID: 3871353
[TBL] [Abstract][Full Text] [Related]
10. Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma.
Foss FM; Raubitscheck A; Mulshine JL; Fleisher TA; Reynolds JC; Paik CH; Neumann RD; Boland C; Perentesis P; Brown MR; Frincke JM; Lollo CP; Larson SM; Carrasquillo JA
Clin Cancer Res; 1998 Nov; 4(11):2691-700. PubMed ID: 9829731
[TBL] [Abstract][Full Text] [Related]
11. Lack of T-cell immunity in humans with preexisting anti-mouse immunoglobulin reactivity.
Conry RM; Khazaeli MB; LoBuglio AF
Cancer Res; 1992 Dec; 52(24):6979-82. PubMed ID: 1458491
[TBL] [Abstract][Full Text] [Related]
12. In vivo fate of monoclonal antibody B72.3 in patients with colorectal cancer.
Colcher D; Milenic DE; Ferroni P; Carrasquillo JA; Reynolds JC; Roselli M; Larson SM; Schlom J
J Nucl Med; 1990 Jul; 31(7):1133-42. PubMed ID: 2362192
[TBL] [Abstract][Full Text] [Related]
13. Human IgE, IgG and IgA antibody responses to T101, a murine monoclonal antibody against human lymphocytes: implications for pathogenesis, risk and avoidance of adverse immunologic reactions.
Dykewicz MS; Cranberg JA; Patterson R; Rosen ST; Shaughnessy MA; Zimmer AM
Int Arch Allergy Appl Immunol; 1990; 92(2):131-7. PubMed ID: 2242927
[TBL] [Abstract][Full Text] [Related]
14. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
[TBL] [Abstract][Full Text] [Related]
15. Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival.
Cheung NK; Cheung IY; Canete A; Yeh SJ; Kushner B; Bonilla MA; Heller G; Larson SM
Cancer Res; 1994 Apr; 54(8):2228-33. PubMed ID: 8174131
[TBL] [Abstract][Full Text] [Related]
16. High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.
Kushner BH; Cheung IY; Kramer K; Modak S; Cheung NK
Pediatr Blood Cancer; 2007 Apr; 48(4):430-4. PubMed ID: 16421906
[TBL] [Abstract][Full Text] [Related]
17. Fractionated radioimmunotherapy of B-cell malignancies with 131I-Lym-1.
DeNardo GL; DeNardo SJ; O'Grady LF; Levy NB; Adams GP; Mills SL
Cancer Res; 1990 Feb; 50(3 Suppl):1014s-1016s. PubMed ID: 2297713
[TBL] [Abstract][Full Text] [Related]
18. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants.
Kaminski MS; Kitamura K; Maloney DG; Campbell MJ; Levy R
J Immunol; 1986 Feb; 136(3):1123-30. PubMed ID: 3484499
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
20. Experimental radiotherapy of murine lymphoma with 131I-labeled anti-Thy 1.1 monoclonal antibody.
Badger CC; Krohn KA; Peterson AV; Shulman H; Bernstein ID
Cancer Res; 1985 Apr; 45(4):1536-44. PubMed ID: 3978621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
